man measuring waist

NICE recommend new weight loss jab

NICE have recommended a new drug which could benefit thousands suffering with obesity and help them to lose weight.

The drug known as semaglutide, can be used in adults with at least one weight related condition and a BMI of at least 35kg/m2 and in exceptional circumstance those with a BMI of 30.0kg/m2 to 24.9kg/m2

Semaglutide can only be prescribed for a maximum of two year and must be used as part of a weight management programme such as a tier 3 weight management programme or tier 4 speciality obesity services.

The results of the initial clinical trial found that participants taking semaglutide lost on average 12 percent more of their body weight compared to those taking the placebo.

The drug should be injected once a week using a pre-filled pen, similar to that used to in administering insulin in diabetes patients.

The injection works by supressing appetite and mimicking glucagon-like-peptide-1 (GLP1), a hormone released after eating.

Helen Knight, programme director in the centre for health technology evaluation at NICE, said: “We know that management of overweight and obesity is one of the biggest challenges our health service is facing with nearly two thirds of adults either overweight or obese. It is a lifelong condition that needs medical intervention, has psychological and physical effects, and can affect quality of life.

“But in recent years NICE has been able to recommend a new line of pharmaceutical treatments which have shown that those people using them, alongside changes to their diet and exercise, have been able to reduce their weight.”

The list price for a pack of four semaglutide pre-filled pens (0,24mg, 0.5mg and 1.0mg) is £73.25 (excluding VAT).and could drastically reduce costs for weight-related issues on the NHS.

Currently it costs the NHS an estimated £6.1 billion for treatments related to obesity in the UK, with an estimated 28 percent of adults in England being obsese and a further 36 percent being overweight.

A consultation has begun to make comments on the recommendations, which can be made here before 5pm on Tuesday 1st March 2022.

NHE March/April 22

NHE Jan/Feb 22

Calling time on stop gap solutions

The new edition of NHE’s e-magazine highlights the newest digital innovation, environmental efforts, procurement projects and more with articles from the likes of Lord Victor Adebowale, Chair of the NHS Confederation (pg38), Health Education England and NHS Supply Chain.  

Videos...

View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Events

NHE has created a full calendar of events to address the most important issues that influence the delivery of healthcare services. Over 365 days you'll have the opportunity to hear from a range of highly motivating, informative and inspirational speakers. These speakers will equip you with the knowledge and unique insight to enable you to overcome the challenges that you face.

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all